secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2024-07-09T23:59:59+00:00
Accession:  0001683168-24-004708
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharmaceuticals regains Nasdaq bid price compliance after 20-day period
---------------------------------------------------------------------------

- Received Nasdaq deficiency letter Feb 27, 2024 for bid price below $1.00 for 30 consecutive days.
- On July 5, 2024, Nasdaq confirmed compliance as closing bid price ≥ $1.00 for 20 consecutive business days (June 5 – July 3, 2024).
- Matter is closed; company continues listing on Nasdaq Capital Market under ticker CNSP.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824004708/0001683168-24-004708-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824004708/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-004708

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer